NCT01428505View on ClinicalTrials.gov

[18F]PBR111 and Microglial Activation in Multiple Sclerosis

PHASE2TerminatedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

March 31, 2013

Study Completion Date

March 31, 2013

Conditions
Multiple Sclerosis
Interventions
RADIATION

[18F]PBR111

radioligand to assess binding to TSPO

Trial Locations (1)

W12 0NN

GSK Investigational Site, London

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY